These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 17593082

  • 1. Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patients.
    Amen F, Horncastle D, Elderfield K, Banham AH, Bower M, Macdonald D, Kanfer E, Naresh KN.
    Histopathology; 2007 Jul; 51(1):70-9. PubMed ID: 17593082
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.
    Muris JJ, Meijer CJ, Vos W, van Krieken JH, Jiwa NM, Ossenkoppele GJ, Oudejans JJ.
    J Pathol; 2006 Apr; 208(5):714-23. PubMed ID: 16400625
    [Abstract] [Full Text] [Related]

  • 3. Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
    Nyman H, Jerkeman M, Karjalainen-Lindsberg ML, Banham AH, Enblad G, Leppä S.
    Eur J Haematol; 2009 May; 82(5):364-72. PubMed ID: 19141121
    [Abstract] [Full Text] [Related]

  • 4. MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type.
    Yoon SO, Jeon YK, Paik JH, Kim WY, Kim YA, Kim JE, Kim CW.
    Histopathology; 2008 Aug; 53(2):205-17. PubMed ID: 18752503
    [Abstract] [Full Text] [Related]

  • 5. Serum levels of inflammatory cytokines at diagnosis correlate to the bcl-6 and CD10 defined germinal centre (GC) phenotype and bcl-2 expression in patients with diffuse large B-cell lymphoma.
    Pedersen LM, Jürgensen GW, Johnsen HE.
    Br J Haematol; 2005 Mar; 128(6):813-9. PubMed ID: 15755285
    [Abstract] [Full Text] [Related]

  • 6. Expression and prognostic implications of cell cycle regulatory molecules, p16, p21, p27, p14 and p53 in germinal centre and non-germinal centre B-like diffuse large B-cell lymphomas.
    Paik JH, Jeon YK, Park SS, Kim YA, Kim JE, Huh J, Lee SS, Kim WH, Kim CW.
    Histopathology; 2005 Sep; 47(3):281-91. PubMed ID: 16115229
    [Abstract] [Full Text] [Related]

  • 7. SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma.
    Jang KY, Hwang SH, Kwon KS, Kim KR, Choi HN, Lee NR, Kwak JY, Park BH, Park HS, Chung MJ, Kang MJ, Lee DG, Kim HS, Shim H, Moon WS.
    Am J Surg Pathol; 2008 Oct; 32(10):1523-31. PubMed ID: 18724249
    [Abstract] [Full Text] [Related]

  • 8. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.
    Ree HJ, Yang WI, Kim CW, Huh J, Lee SS, Cho EY, Ko YH, Charney D.
    Hum Pathol; 2001 Sep; 32(9):954-62. PubMed ID: 11567225
    [Abstract] [Full Text] [Related]

  • 9. CD10 and Bcl-2 expression combined with the International Prognostic Index can identify subgroups of patients with diffuse large-cell lymphoma with very good or very poor prognoses.
    Biasoli I, Morais JC, Scheliga A, Milito CB, Romano S, Land M, Pulcheri W, Spector N.
    Histopathology; 2005 Mar; 46(3):328-33. PubMed ID: 15720419
    [Abstract] [Full Text] [Related]

  • 10. Primary lymphoma of bone: extranodal lymphoma with favourable survival independent of germinal centre, post-germinal centre or indeterminate phenotype.
    Heyning FH, Hogendoorn PC, Kramer MH, Holland CT, Dreef E, Jansen PM.
    J Clin Pathol; 2009 Sep; 62(9):820-4. PubMed ID: 19734480
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients.
    Liu YH, Xu FP, Zhuang HG, Lai KC, Xie D, Luo DL, Li L, Luo XL, Xu J, Zhang MH, Zhang F, Li HM.
    Hum Pathol; 2008 Jun; 39(6):875-84. PubMed ID: 18440593
    [Abstract] [Full Text] [Related]

  • 12. [Primary gastrointestinal diffuse large B-cell lymphoma: an immunohistochemical and prognostic study of 90 cases].
    Lin L, Min M, Bi CF, Wang XQ, Luo TY, Zhao S, Zhang WY, Liu WP.
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):220-6. PubMed ID: 21615994
    [Abstract] [Full Text] [Related]

  • 13. BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma.
    Obermann EC, Csato M, Dirnhofer S, Tzankov A.
    J Clin Pathol; 2009 Oct; 62(10):903-7. PubMed ID: 19783718
    [Abstract] [Full Text] [Related]

  • 14. Expression of transmembrane adaptor protein PAG/Cbp in diffuse large B-cell lymphoma: immunohistochemical study of 73 cases.
    Svec A.
    Pathol Res Pract; 2007 Oct; 203(4):193-8. PubMed ID: 17382485
    [Abstract] [Full Text] [Related]

  • 15. Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma.
    Linderoth J, Ehinger M, Akerman M, Cavallin-Ståhl E, Enblad G, Erlanson M, Jerkeman M.
    Eur J Haematol; 2007 Aug; 79(2):146-9. PubMed ID: 17635238
    [Abstract] [Full Text] [Related]

  • 16. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
    Fu K, Weisenburger DD, Choi WW, Perry KD, Smith LM, Shi X, Hans CP, Greiner TC, Bierman PJ, Bociek RG, Armitage JO, Chan WC, Vose JM.
    J Clin Oncol; 2008 Oct 01; 26(28):4587-94. PubMed ID: 18662967
    [Abstract] [Full Text] [Related]

  • 17. Bcl-2 and BLIMP-1 expression predict worse prognosis in gastric diffuse large B cell lymphoma (DLCBL) while other markers for nodal DLBCL are not useful.
    Martin-Arruti M, Vaquero M, Díaz de Otazu R, Zabalza I, Ballesteros J, Roncador G, García-Orad A.
    Histopathology; 2012 Apr 01; 60(5):785-92. PubMed ID: 22321048
    [Abstract] [Full Text] [Related]

  • 18. Comparison of two different immunohistochemical algorithms identifying prognostic subgroups of DLBCL.
    Jabłońska J, Jesionek-Kupnicka D, Potemski P, Kowalik A, Sygut J, Kordek R.
    Pol J Pathol; 2010 Apr 01; 61(3):124-32. PubMed ID: 21225494
    [Abstract] [Full Text] [Related]

  • 19. [Prevalence of germinal center B-cell-like and non-germinal center B-cell-like types of diffuse large B-cell lymphoma in Shanghai, China].
    Chen Y, Chen H, Fu K, Zhu XZ, Irons R.
    Zhonghua Bing Li Xue Za Zhi; 2010 May 01; 39(5):313-8. PubMed ID: 20654154
    [Abstract] [Full Text] [Related]

  • 20. The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome.
    Barrans SL, Evans PA, O'Connor SJ, Kendall SJ, Owen RG, Haynes AP, Morgan GJ, Jack AS.
    Clin Cancer Res; 2003 Jun 01; 9(6):2133-9. PubMed ID: 12796378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.